Biogenics was established in April 1997 as a partnership, with the innovative idea of contract marketing of pharmaceutical products. This new idea attracted a number of multinational pharmaceuticals to Biogenics, as clients. Biogenics’ first agreement was signed with Novartis Pharma (formerly Sandoz) for ten of its products in March 1998. Very soon, similar agreements with Abbott, Pfizer, Eli Lilly, Jansen Cilag, and Gold Shield, UK followed.

Realizing the need of the time, Biogenics soon started getting its own pharmaceutical products toll manufactured by Highnoon Laboratories, Lahore. Today Biogenics has a strong portfolio of its own pharmaceutical brands, with strengths in the gastroenterology, cardiovascular, anti-hypertension, anti-arthritis, anti-allergic and gynecology segments. Besides its pharma brands, Biogenics also has a diverse and strong portfolio of Consumer Healthcare brands which it manufactures and markets.

Our first pharmaceutical product was launched in April 2000. Many of our products like Helezol, Angiocard, Fibrocol, Artonec, Hamdam and Calnox have become success stories since then.

Currently, Biogenics has around a 100 Medical and Sales Reps and 20 Managers, divided in three teams, covering the entire Pakistan.